BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 10, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Deals roundup: Orthofix sheds sports medicine unit to WSHP for $157 million

April 25, 2012
By Omar Ford
Orthofix (Lewisville, Texas) is narrowing its focus and concentrating more on the spine and orthopedics space with the news of it divesting its sports medicine business unit Breg (Carlsbag, California).
Read More

Abbott, St. Jude to promote diagnostic, cardio offerings

April 24, 2012
By Omar Ford
Two of the largest firms in med-tech are working together to broaden both their diagnostics and cardiovascular offerings. Abbott (Abbott Park, Illinois) and St. Jude Medical (St. Paul, Minnesota) reported the formation of Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.
Read More

Washington roundup: AdvaMed reveals strategic plan to help preserve innovation

April 20, 2012
By Omar Ford
It might sound clich , but the stakes have never been so high in the medical device space. The growth of emerging markets, the upcoming medical device excise tax, and the Physician Payment Sunshine act are major issues that will probably offer up a significant change in the landscape and the way firms conduct business. The Advanced Medical Technology Association (AdvaMed; Washington) revealed its recently completed three-year strategic plan that it said would address some of these issues and help the industry maintain its competitive edge and encourage innovation.
Read More

Washington roundup: Study shows that competitive bidding program leads to savings

April 19, 2012
By Omar Ford

Study shows agent could aid in detection of Alzheimer's Disease

April 18, 2012
By Omar Ford

Deals roundup: PHL to acquire imaging research portfolio from Bayer Pharma

April 17, 2012
By Omar Ford

Survey shows many unprepared for Sunshine Act implications

April 16, 2012
By Omar Ford

Sunshine Heart looking to start C-Pulse pivotal trial in 3Q12

April 13, 2012
By Omar Ford

Restructuring roundup: HemCon Technologies files for Chapter 11 protection

April 12, 2012
By Omar Ford

CASMed gains favorable results from Fore-Sight study

April 9, 2012
By Omar Ford
Previous 1 2 … 132 133 134 135 136 137 138 139 140 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 9, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing